vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and SunOpta Inc. (STKL). Click either name above to swap in a different company.
SunOpta Inc. is the larger business by last-quarter revenue ($205.4M vs $164.7M, roughly 1.2× PTC THERAPEUTICS, INC.). SunOpta Inc. runs the higher net margin — 0.4% vs -82.0%, a 82.4% gap on every dollar of revenue. On growth, SunOpta Inc. posted the faster year-over-year revenue change (16.6% vs -22.7%). SunOpta Inc. produced more free cash flow last quarter ($12.1M vs $-36.6M). Over the past eight quarters, SunOpta Inc.'s revenue compounded faster (7.4% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.
PTCT vs STKL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $205.4M |
| Net Profit | $-135.0M | $816.0K |
| Gross Margin | — | 12.4% |
| Operating Margin | -43.3% | 3.3% |
| Net Margin | -82.0% | 0.4% |
| Revenue YoY | -22.7% | 16.6% |
| Net Profit YoY | -104.8% | 113.1% |
| EPS (diluted) | $-1.63 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $164.7M | — | ||
| Q3 25 | $211.0M | $205.4M | ||
| Q2 25 | $178.9M | $191.5M | ||
| Q1 25 | $1.2B | $201.6M | ||
| Q4 24 | $213.2M | $193.9M | ||
| Q3 24 | $196.8M | $175.9M | ||
| Q2 24 | $186.7M | $169.5M | ||
| Q1 24 | $210.1M | $184.4M |
| Q4 25 | $-135.0M | — | ||
| Q3 25 | $15.9M | $816.0K | ||
| Q2 25 | $-64.8M | $4.4M | ||
| Q1 25 | $866.6M | $4.8M | ||
| Q4 24 | $-65.9M | $-8.7M | ||
| Q3 24 | $-106.7M | $-6.2M | ||
| Q2 24 | $-99.2M | $-5.3M | ||
| Q1 24 | $-91.6M | $2.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | 12.4% | ||
| Q2 25 | — | 14.8% | ||
| Q1 25 | — | 15.0% | ||
| Q4 24 | — | 10.9% | ||
| Q3 24 | — | 13.0% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | — | 16.8% |
| Q4 25 | -43.3% | — | ||
| Q3 25 | 1.4% | 3.3% | ||
| Q2 25 | -19.5% | 5.5% | ||
| Q1 25 | 82.5% | 5.2% | ||
| Q4 24 | -76.2% | 1.4% | ||
| Q3 24 | -27.7% | 0.5% | ||
| Q2 24 | -21.5% | 1.2% | ||
| Q1 24 | -21.6% | 5.5% |
| Q4 25 | -82.0% | — | ||
| Q3 25 | 7.5% | 0.4% | ||
| Q2 25 | -36.3% | 2.3% | ||
| Q1 25 | 73.7% | 2.4% | ||
| Q4 24 | -30.9% | -4.5% | ||
| Q3 24 | -54.2% | -3.5% | ||
| Q2 24 | -53.1% | -3.1% | ||
| Q1 24 | -43.6% | 1.6% |
| Q4 25 | $-1.63 | — | ||
| Q3 25 | $0.20 | $0.01 | ||
| Q2 25 | $-0.83 | $0.03 | ||
| Q1 25 | $10.04 | $0.04 | ||
| Q4 24 | $-0.85 | $-0.08 | ||
| Q3 24 | $-1.39 | $-0.05 | ||
| Q2 24 | $-1.29 | $-0.04 | ||
| Q1 24 | $-1.20 | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $2.2M |
| Total DebtLower is stronger | — | $250.8M |
| Stockholders' EquityBook value | $-205.3M | $162.8M |
| Total Assets | $2.9B | $694.1M |
| Debt / EquityLower = less leverage | — | 1.54× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.7B | $2.2M | ||
| Q2 25 | $2.0B | $2.2M | ||
| Q1 25 | $2.0B | $2.3M | ||
| Q4 24 | $1.1B | $1.6M | ||
| Q3 24 | $1.0B | $2.9M | ||
| Q2 24 | $1.1B | $3.2M | ||
| Q1 24 | $884.8M | $1.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $250.8M | ||
| Q2 25 | — | $263.3M | ||
| Q1 25 | — | $260.6M | ||
| Q4 24 | — | $265.2M | ||
| Q3 24 | — | $289.9M | ||
| Q2 24 | — | $303.1M | ||
| Q1 24 | — | $258.8M |
| Q4 25 | $-205.3M | — | ||
| Q3 25 | $-155.8M | $162.8M | ||
| Q2 25 | $-206.5M | $159.8M | ||
| Q1 25 | $-185.8M | $154.8M | ||
| Q4 24 | $-1.1B | $148.6M | ||
| Q3 24 | $-1.1B | $155.0M | ||
| Q2 24 | $-980.2M | $158.8M | ||
| Q1 24 | $-893.9M | $163.6M |
| Q4 25 | $2.9B | — | ||
| Q3 25 | $2.6B | $694.1M | ||
| Q2 25 | $2.6B | $704.9M | ||
| Q1 25 | $2.7B | $690.7M | ||
| Q4 24 | $1.7B | $668.5M | ||
| Q3 24 | $1.8B | $699.3M | ||
| Q2 24 | $1.9B | $704.7M | ||
| Q1 24 | $1.8B | $671.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.54× | ||
| Q2 25 | — | 1.65× | ||
| Q1 25 | — | 1.68× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | 1.91× | ||
| Q1 24 | — | 1.58× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | $16.3M |
| Free Cash FlowOCF − Capex | $-36.6M | $12.1M |
| FCF MarginFCF / Revenue | -22.3% | 5.9% |
| Capex IntensityCapex / Revenue | 1.4% | 2.1% |
| Cash ConversionOCF / Net Profit | — | 20.03× |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | $36.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.3M | — | ||
| Q3 25 | $-66.3M | $16.3M | ||
| Q2 25 | $-58.3M | $-4.5M | ||
| Q1 25 | $870.1M | $22.3M | ||
| Q4 24 | $-30.0M | $33.1M | ||
| Q3 24 | $-77.0M | $17.2M | ||
| Q2 24 | $-71.5M | $-5.6M | ||
| Q1 24 | $70.8M | $5.3M |
| Q4 25 | $-36.6M | — | ||
| Q3 25 | $-69.7M | $12.1M | ||
| Q2 25 | $-59.6M | $-9.2M | ||
| Q1 25 | $868.4M | $9.5M | ||
| Q4 24 | $-33.8M | $24.0M | ||
| Q3 24 | $-77.5M | $11.7M | ||
| Q2 24 | $-78.8M | $-15.3M | ||
| Q1 24 | $61.2M | $-2.3M |
| Q4 25 | -22.3% | — | ||
| Q3 25 | -33.1% | 5.9% | ||
| Q2 25 | -33.3% | -4.8% | ||
| Q1 25 | 73.8% | 4.7% | ||
| Q4 24 | -15.8% | 12.4% | ||
| Q3 24 | -39.4% | 6.6% | ||
| Q2 24 | -42.2% | -9.0% | ||
| Q1 24 | 29.1% | -1.2% |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.6% | 2.1% | ||
| Q2 25 | 0.7% | 2.5% | ||
| Q1 25 | 0.1% | 6.3% | ||
| Q4 24 | 1.8% | 4.7% | ||
| Q3 24 | 0.3% | 3.2% | ||
| Q2 24 | 4.0% | 5.7% | ||
| Q1 24 | 4.6% | 4.1% |
| Q4 25 | — | — | ||
| Q3 25 | -4.17× | 20.03× | ||
| Q2 25 | — | -1.03× | ||
| Q1 25 | 1.00× | 4.63× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PTCT
Segment breakdown not available.
STKL
| Beverages And Broths | $161.4M | 79% |
| Fruit Snacks | $40.9M | 20% |
| Ingredients | $3.1M | 2% |
